The Infectious Diseases Diagnostics Market is stipulated to grow at a remarkable rate In Upcoming Years. Cybersecurity is inevitable for verticals all across in wake of cyber intruders. As such, reliable, secure, and fast wireless and wired connectivity are being called for concerning devices, applications, and users across the entire enterprise.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11413
According to the latest market report published by Persistence Market Research, titled “Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”. The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.
The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024. Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the largest segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y – o – Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are expected to gain upward momentum in 2016, growing at 8.9% in terms of revenue, the fastest among disease indication segment.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
Company Profiles:
- Becton Dickinson & Company
- Cepheid, Inc.
- Abbott Laboratories
- bioMerieux SA
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Alera Inc.
- DiaSorin S.p.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Other
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11413
Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and large applications in diagnosis of several infectious diseases is gaining traction. Consumption demand for cell culture test kits will witness a growth rate of 7.2 % in 2016 over 2015.
Diagnostic centers end user segment is expected to register highest CAGR in terms of revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics centers, worldwide and a large number of patient pool depending on diagnostics centers for diagnosis of infectious diseases is expected to increase demand for diagnostics tests among diagnostics centers. The diagnostics centers end user segment will witness a growth rate of 7.4 % in 2016 over 2015.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/11413
PMR Long-term Outlook: PMR projects the global infectious disease diagnostics market to witness moderate growth during the forecast period 2016–2024. APAC will continue to remain the largest market for infectious disease diagnostics, registering a CAGR of 7.9% over the forecast period.
Related Reports:
Infection Surveillance Solutions Market
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
1-2-1 Kinshi
Arca Central Building 14/F
Tokyo, 130-0013
Japan
18888633700